ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2879

Prognostic Value Of Minor Salivary Gland Assessments In Primary Sjögren’s Syndrome

Anna Risselada1, A.a. Kruize2, J.A.G. van Roon3, F.P.J.G. Lafeber4 and J.W.J. Bijlsma4, 1Clinical immunology and Rheumatology, University Medical Center Utrecht, Utrecht, Netherlands, 2Rheumatology and Clinical Immunology, University Medical Center Utrecht, Utrecht, Netherlands, 3Rheumatology & Clinical Immunology/Lab Translational Immunology, University Medical Center Utrecht, Utrecht, Netherlands, 4Rheumatology & Clinical Immunology, University Medical Center Utrecht, Utrecht, Netherlands

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: Disease Activity, histopathologic and salivary gland, Sjogren's syndrome

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Sjögren's Syndrome: Clinical Advances

Session Type: Abstract Submissions (ACR)

Background/Purpose:

Salivary gland assessment is important for diagnosing primary Sjögren’s syndrome (pSS), as the lymphocytic focus score (LFS) is part of pSS classification criteria. Quantitative immunohistology (QIH) is another technique used for assessing pSS in which the percentage of immunoglobulin-specific plasma cells is measured, with IgA <70% and/or IgM >10% as positive criteria.  Our objective was to investigate the prognostic value of minor salivary gland assessment (LFS and QIH) for disease severity of pSS.

Methods:

Medical charts of all patients with pSS according to the 2002 classification criteria who attended our outpatient clinic for at least one year from 1998 to July 2011 were analyzed. In total, 174 patients had documented minor salivary gland histology and were included for this analysis. Histology results (LFS and percentages of IgA, IgM and IgG plasma cells) were compared with disease outcomes as non-Hodgkin lymphoma (NHL) and clinical scores: cumulative EULAR Sjögren’s Syndrome disease activity index (ESSDAI) and the number of extraglandular manifestations (EGM) during disease course.

Results:

Mean age at pSS diagnosis was 47 ± 14 years and median follow-up after biopsy was 105 months (range 10 – 408). LFS ≥1 were seen in 99%, <70% IgA-positive plasma cells in 90%, and >10% IgM-positive plasma cells in 71% of patients, respectively. The number of foci correlated to a decrease in the percentage of IgA-positive plasma cells (R=0.315, p=0.0001), but not to the percentage of IgM- or IgG-positive plasma cells.

NHL developed in 16 patients (9%). The mean LFS was significantly higher in patients with NHL (3.0 ± 0.9 versus 2.3 ± 1.1; p=0.021). The threshold of ≥3 foci had a positive predictive value of 16% for development of lymphoma, and a negative predictive value of 98% (OR 7.9; p=0,008). QIH results could not predict lymphoma development.

Only LFS ≥3 contributed significantly and independently to NHL development in a hierarchical multiple regression model, correcting for presence of anti-SSA/SSB antibodies (beta 0.244; p=0.017). Cumulative ESSDAI and EGM were significantly correlated to LFS, a decreased percentage of IgA-positive and an increased percentage of IgM-positive plasma cells (R range 0.166 – 0.284; p≤0.04), but not to the percentage of IgG-positive plasma cells.

Conclusion:

Routinely performed minor salivary gland assessments have important prognostic value. The number of lymphocyte foci can be used to identify patients with increased lymphoma risk.

Acknowledgements:

We would like to thank J.M. van Woerkom, R. Goldschmeding and the pathology department of the University Medical Center Utrecht for their work on the minor salivary gland assessments.


Disclosure:

A. Risselada,
None;

A. A. Kruize,
None;

J. A. G. van Roon,
None;

F. P. J. G. Lafeber,
None;

J. W. J. Bijlsma,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/prognostic-value-of-minor-salivary-gland-assessments-in-primary-sjogrens-syndrome/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology